Skip to main content
. Author manuscript; available in PMC: 2011 Dec 12.
Published in final edited form as: J Immunol. 2009 Oct 19;183(10):6359–6368. doi: 10.4049/jimmunol.0902473

Figure 2. Peripheral J558 Id+ B cell development in the peritoneal cavity and lymph nodes.

Figure 2

(A) FACS analysis of J558 Id+ B cell enrichment in B1a (CD5+ IgM hi Mac-1+ B220 int) B1b (CD5- IgM hi Mac-1+ B220 int) and B2 (CD5- IgM int Mac-1- B220 hi) from the peritoneal cavities of VHJ558 transgenic (black lines) and littermate controls (grey histograms). (B) Total numbers of J558 Id+ B cell subsets in the peritoneal cavity. (C) FACS analysis of J558 Id+ MZ (CD21 hi CD23- B220+ IgM hi CD9+), preMZ (CD21 hi CD23+ B220+ CD9+), and RF B cells (CD21 int CD23+ B220+ IgM int CD9-) in the mesenteric lymph nodes of VHJ558 transgenic (black lines) and littermate controls (grey histograms). (D) Total numbers of J558 Id+ B cells in the different subsets in the lymph nodes.